Do analysts prefer BMRA or RVP?

Biomerica presently has a consensus target price of $9.00, suggesting a potential upside of 391.80%. Given Biomerica's stronger consensus rating and higher probable upside, equities analysts plainly believe Biomerica is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer CUPR or BMRA?

Biomerica has a consensus price target of $9.00, suggesting a potential upside of 391.80%. Given Biomerica's higher possible upside, analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, CUPR or BMRA?

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 295.75 -$3.63M N/A N/A Biomerica $4.45M 1.27 -$3.78M -$1.27 N/A

Do analysts recommend BMRA or LUCY?

Biomerica currently has a consensus price target of $9.00, suggesting a potential upside of 391.80%. Given Biomerica's higher possible upside, equities research analysts plainly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to BMRA or LUCY?

In the previous week, Innovative Eyewear had 3 more articles in the media than Biomerica. MarketBeat recorded 5 mentions for Innovative Eyewear and 2 mentions for Biomerica. Biomerica's average media sentiment score of 0.37 beat Innovative Eyewear's score of 0.11 indicating that Biomerica is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biomerica 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, NXGL or BMRA?

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NexGel $12.07M 0.16 -$3M -$0.71 N/A Biomerica $4.45M 1.27 -$3.78M -$1.27 N/A

Is NXGL or BMRA more profitable?

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -84.79%. Biomerica's return on equity of -97.19% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets NexGel -51.26% -121.18% -41.15% Biomerica -84.79% -97.19% -61.57%

Does the media favor NXGL or BMRA?

In the previous week, NexGel had 8 more articles in the media than Biomerica. MarketBeat recorded 10 mentions for NexGel and 2 mentions for Biomerica. Biomerica's average media sentiment score of 0.37 beat NexGel's score of 0.32 indicating that Biomerica is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NexGel 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Biomerica 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BMRA or LUCYW?

Biomerica presently has a consensus price target of $9.00, indicating a potential upside of 391.80%. Given Biomerica's stronger consensus rating and higher possible upside, equities analysts plainly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, BMRA or LUCYW?

Innovative Eyewear has lower revenue, but higher earnings than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $4.45M 1.27 -$3.78M -$1.27 N/A Innovative Eyewear $3.41M N/A N/A N/A N/A

Biomerica (BMRA) Competitors

$1.83 -0.06 (-3.17%)

As of 10/9/2026 04:00 PM Eastern

Compare

BMRA vs. RVP, CUPR, LUCY, NXGL, and LUCYW

Should you buy Biomerica stock or one of its competitors? Biomerica's main competitors and comparable companies include Retractable Technologies (RVP), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCY), NexGel (NXGL), and Innovative Eyewear (LUCYW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Biomerica compare to Retractable Technologies?

Biomerica (NASDAQ:BMRA) and Retractable Technologies (NYSE:RVP) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

Retractable Technologies has a net margin of -41.11% compared to Biomerica's net margin of -84.79%. Retractable Technologies' return on equity of -17.15% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-84.79%	-97.19%	-61.57%
Retractable Technologies	-41.11%	-17.15%	-9.33%

In the previous week, Biomerica had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Biomerica and 0 mentions for Retractable Technologies. Biomerica's average media sentiment score of 0.37 beat Retractable Technologies' score of 0.00 indicating that Biomerica is being referred to more favorably in the media.

Company	Overall Sentiment
Biomerica	Neutral
Retractable Technologies	Neutral

Biomerica presently has a consensus target price of $9.00, suggesting a potential upside of 391.80%. Given Biomerica's stronger consensus rating and higher probable upside, equities analysts plainly believe Biomerica is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Biomerica has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.2, suggesting that its share price is 20% more volatile than the broader market.

22.3% of Biomerica shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Biomerica has higher earnings, but lower revenue than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Biomerica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$4.45M	1.27	-$3.78M	-$1.27	N/A
Retractable Technologies	$33.90M	0.59	-$7.01M	-$0.12	N/A

Summary

Retractable Technologies beats Biomerica on 8 of the 15 factors compared between the two stocks.

How does Biomerica compare to Cuprina Holdings (Cayman)?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Biomerica's net margin of -84.79%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
Biomerica	-84.79%	-97.19%	-61.57%

22.3% of Biomerica shares are owned by institutional investors. 18.0% of Biomerica shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Biomerica has a consensus price target of $9.00, suggesting a potential upside of 391.80%. Given Biomerica's higher possible upside, analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Biomerica had 1 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 2 mentions for Biomerica and 1 mentions for Cuprina Holdings (Cayman). Biomerica's average media sentiment score of 0.37 beat Cuprina Holdings (Cayman)'s score of 0.00 indicating that Biomerica is being referred to more favorably in the news media.

Company	Overall Sentiment
Cuprina Holdings (Cayman)	Neutral
Biomerica	Neutral

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	295.75	-$3.63M	N/A	N/A
Biomerica	$4.45M	1.27	-$3.78M	-$1.27	N/A

Cuprina Holdings (Cayman) has a beta of -0.1, meaning that its share price is 110% less volatile than the broader market. Comparatively, Biomerica has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market.

Summary

Biomerica beats Cuprina Holdings (Cayman) on 7 of the 12 factors compared between the two stocks.

How does Biomerica compare to Innovative Eyewear?

Biomerica (NASDAQ:BMRA) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

22.3% of Biomerica shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Biomerica currently has a consensus price target of $9.00, suggesting a potential upside of 391.80%. Given Biomerica's higher possible upside, equities research analysts plainly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Innovative Eyewear had 3 more articles in the media than Biomerica. MarketBeat recorded 5 mentions for Innovative Eyewear and 2 mentions for Biomerica. Biomerica's average media sentiment score of 0.37 beat Innovative Eyewear's score of 0.11 indicating that Biomerica is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biomerica	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Biomerica has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.74, meaning that its stock price is 174% more volatile than the broader market.

Biomerica has higher revenue and earnings than Innovative Eyewear. Biomerica is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$4.45M	1.27	-$3.78M	-$1.27	N/A
Innovative Eyewear	$3.41M	2.31	-$7.59M	-$1.29	N/A

Biomerica has a net margin of -84.79% compared to Innovative Eyewear's net margin of -225.26%. Innovative Eyewear's return on equity of -88.90% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-84.79%	-97.19%	-61.57%
Innovative Eyewear	-225.26%	-88.90%	-80.34%

Summary

Biomerica beats Innovative Eyewear on 9 of the 15 factors compared between the two stocks.

How does Biomerica compare to NexGel?

NexGel (NASDAQ:NXGL) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$12.07M	0.16	-$3M	-$0.71	N/A
Biomerica	$4.45M	1.27	-$3.78M	-$1.27	N/A

NexGel has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Biomerica has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market.

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -84.79%. Biomerica's return on equity of -97.19% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-51.26%	-121.18%	-41.15%
Biomerica	-84.79%	-97.19%	-61.57%

NexGel currently has a consensus target price of $2.00, indicating a potential upside of 898.50%. Biomerica has a consensus target price of $9.00, indicating a potential upside of 391.80%. Given NexGel's stronger consensus rating and higher probable upside, equities analysts plainly believe NexGel is more favorable than Biomerica.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, NexGel had 8 more articles in the media than Biomerica. MarketBeat recorded 10 mentions for NexGel and 2 mentions for Biomerica. Biomerica's average media sentiment score of 0.37 beat NexGel's score of 0.32 indicating that Biomerica is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Biomerica	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

2.2% of NexGel shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 19.8% of NexGel shares are held by company insiders. Comparatively, 18.0% of Biomerica shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

NexGel beats Biomerica on 11 of the 15 factors compared between the two stocks.

How does Biomerica compare to Innovative Eyewear?

Biomerica (NASDAQ:BMRA) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

22.3% of Biomerica shares are held by institutional investors. 18.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Innovative Eyewear has a net margin of 0.00% compared to Biomerica's net margin of -84.79%. Innovative Eyewear's return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-84.79%	-97.19%	-61.57%
Innovative Eyewear	N/A	N/A	N/A

Biomerica presently has a consensus price target of $9.00, indicating a potential upside of 391.80%. Given Biomerica's stronger consensus rating and higher possible upside, equities analysts plainly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Biomerica and Biomerica both had 2 articles in the media. Innovative Eyewear's average media sentiment score of 0.80 beat Biomerica's score of 0.37 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company	Overall Sentiment
Biomerica	Neutral
Innovative Eyewear	Positive

Innovative Eyewear has lower revenue, but higher earnings than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$4.45M	1.27	-$3.78M	-$1.27	N/A
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A

Summary

Biomerica beats Innovative Eyewear on 5 of the 9 factors compared between the two stocks.

Get Biomerica News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMRA vs. The Competition

Export

Metric	Biomerica	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.84M	$5.43B	$7.16B	$13.21B
Dividend Yield	N/A	1.77%	2.53%	16.37%
P/E Ratio	-1.44	25.57	275.30	26.16
Price / Sales	1.27	83.34	635.97	107.53
Price / Cash	N/A	31.87	76.38	53.09
Price / Book	2.15	5.95	11.22	6.33
Net Income	-$3.78M	$146.18M	$3.50B	$382.15M
7 Day Performance	-16.59%	-0.28%	-0.89%	-1.40%
1 Month Performance	-17.75%	-1.88%	-4.42%	-3.47%
1 Year Performance	-35.34%	5.45%	7.03%	1.18%

Biomerica Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMRA Biomerica	3.1763 of 5 stars	$1.83 -3.2%	$9.00 +391.8%	-38.0%	$5.84M	$4.45M	N/A	50	News Coverage Positive News
RVP Retractable Technologies	N/A	$0.69 -0.6%	N/A	-35.5%	$20.75M	$33.90M	N/A	201
CUPR Cuprina Holdings (Cayman)	0.7643 of 5 stars	$2.37 +17.9%	N/A	N/A	$16.61M	$49.89K	N/A	10	Gap Down
LUCY Innovative Eyewear	0.6442 of 5 stars	$0.92 +0.1%	N/A	-54.4%	$8.05M	$2.66M	N/A	13	News Coverage Positive News
NXGL NexGel	2.6599 of 5 stars	$0.18 flat	$2.00 +1,036.4%	-92.5%	$1.72M	$11.42M	N/A	19	Short Interest Increase Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BMRA) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biomerica (BMRA) Competitors

BMRA vs. RVP, CUPR, LUCY, NXGL, and LUCYW

How does Biomerica compare to Retractable Technologies?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Summary

How does Biomerica compare to Innovative Eyewear?

Summary

How does Biomerica compare to NexGel?

Summary

How does Biomerica compare to Innovative Eyewear?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biomerica (BMRA) Competitors

BMRA vs. RVP, CUPR, LUCY, NXGL, and LUCYW

How does Biomerica compare to Retractable Technologies?

Is BMRA or RVP more profitable?

Does the media prefer BMRA or RVP?

Do analysts prefer BMRA or RVP?

Which has more risk & volatility, BMRA or RVP?

Do institutionals & insiders have more ownership in BMRA or RVP?

Which has higher earnings and valuation, BMRA or RVP?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Is CUPR or BMRA more profitable?

Do insiders and institutionals have more ownership in CUPR or BMRA?

Do analysts prefer CUPR or BMRA?

Does the media prefer CUPR or BMRA?

Which has better earnings and valuation, CUPR or BMRA?

Which has more volatility & risk, CUPR or BMRA?

Summary

How does Biomerica compare to Innovative Eyewear?

Do institutionals and insiders hold more shares of BMRA or LUCY?

Do analysts recommend BMRA or LUCY?

Does the media refer more to BMRA or LUCY?

Which has more volatility and risk, BMRA or LUCY?

Which has stronger valuation and earnings, BMRA or LUCY?

Is BMRA or LUCY more profitable?

Summary

How does Biomerica compare to NexGel?

Which has preferable earnings and valuation, NXGL or BMRA?

Which has more volatility and risk, NXGL or BMRA?

Is NXGL or BMRA more profitable?

Do analysts rate NXGL or BMRA?

Does the media favor NXGL or BMRA?

Do institutionals & insiders hold more shares of NXGL or BMRA?

Summary

How does Biomerica compare to Innovative Eyewear?

Do insiders and institutionals believe in BMRA or LUCYW?

Is BMRA or LUCYW more profitable?

Do analysts recommend BMRA or LUCYW?

Does the media refer more to BMRA or LUCYW?

Which has better earnings and valuation, BMRA or LUCYW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools